Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19COVID-19 이력에 따른 백신 접종을 하지 않은 미국 성인의 SARS-CoV-2 항체 유병률 및 지속성Article Published on 2022-03-152022-09-12 Journal: JAMA [Category] MERS, SARS, 진단, [키워드] COVID-19 COVID-19 infection history natural immunity SARS-CoV-2 SARS-CoV-2 antibody serologic testing [DOI] 10.1001/jama.2022.1393 PMC 바로가기 [Article Type] Article
Long-term immune responses in patients with confirmed novel coronavirus disease-2019: a 9-month prospective cohort study in Shanghai, China참신한 코로나 바이러스 질병 환자의 장기 면역 반응 -2019 : 중국 상하이에서 9 개월 전망 코호트 연구Research Article Published on 2022-03-102022-09-01 Journal: BMC Infectious Diseases [Category] MERS, SARS, 진단, [키워드] 95% CI 95% confidence interval adjusted odds ratio anti-SARS-CoV-2 IgG antibodies antibody blood sample Blood samples China cigarette smoking cohort study COVID-19 declined disease estimating equation Generalized IgG IgM illness onset immune response Immunity longitudinal mitigate natural immunity natural infection Novel coronavirus pandemic Patient patients peaked Prevent prospective cohort study Questionnaires remained remains uncertain reported symptom Result SARS-CoV-2 self-reported symptom Self-reported symptoms Seroconversion SEROLOGICAL STUDY seropositive Shanghai significantly smoking subject suggested tested Transmission virus [DOI] 10.1186/s12879-022-07173-0 PMC 바로가기 [Article Type] Research Article
Risk of Symptomatic Infection During a Second Coronavirus Disease 2019 Wave in Severe Acute Respiratory Syndrome Coronavirus 2-Seropositive Individuals중증 급성 호흡기 증후군 코로나바이러스 2-혈청 양성 개인에서 두 번째 코로나바이러스 질병 2019 유행 중 증상 감염 위험Article Published on 2022-03-092022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] MERS, SARS, 진단, [키워드] 95% confidence interval analyzed antibody coronavirus disease COVID-19 Immunoglobulin individual Italian natural immunity Reinfection reinfection risk representing respiratory risk SARS-CoV-2 screened second serological Serological screening seropositive participant symptomatic infection Wave [DOI] 10.1093/cid/ciab556 PMC 바로가기 [Article Type] Article
Vaccination conspiracy beliefs among social science & humanities and STEM educated people—An analysis of the mediation pathsResearch Article Published on 2022-03-012022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] age Analysis approach conducted COVID-19 Croatia Engineering Gender Health Healthcare system increasingly indirect effect mathematics natural immunity outbreak positively correlated predictor Science socio-demographic statistically significant technology understanding vaccination Vaccine hesitancy variable [DOI] 10.1371/journal.pone.0264722 PMC 바로가기 [Article Type] Research Article
SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tractArticle Published on 2022-02-222023-06-18 Journal: Cell Reports [Category] COVID19(2023년), MERS, SARS, [키워드] Alpha B.1.1.7 B.1.351 Beta COVID-19 Humoral immunity natural immunity Reinfection SARS-CoV-2 Syrian hamster variants of concern VoC [DOI] 10.1016/j.celrep.2022.110515 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and VaccinesMedicine Published on 2022-02-222022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] Alter amino acid substitution antibody approved B.1.1.529 B.1.351 B.1.617.2 convalescent plasma COVID-19 infection D614G diagnostics disease severity Effectiveness evade Factor Impact Mutation mutation rate mutations N501Y natural immunity non-structural protein omicron P.1 prevalent SARS-CoV-2 SARS-CoV-2 variant Specific Spike protein the SARS-CoV-2 the SARS-CoV-2 genome the spike protein Therapeutics therapy Transmissibility Vaccine Vaccines variant variants of concern variants of interest virulence virus VoC VOCs WHO [DOI] 10.3389/fmed.2022.815389 PMC 바로가기 [Article Type] Medicine
mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variantsSARS-CoV-2 및 이의 고친화성 변이체를 중화하는 데 자연 면역보다 효과적인 mRNA 백신 유도 항체Article Published on 2022-02-162022-09-10 Journal: Scientific Reports [Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 유전자 메커니즘, 진단, [키워드] ACE2 ACE2 binding angiotensin Angiotensin-converting enzyme antibody Antisera binding biochemical Biomarkers blood sample Cohort convalescent COVID-19 diagnostic Diseases effective functional generate high affinity indicate infections Infectious diseases maintain median Medical research Microbiology mRNA mRNA vaccination Mutation N501Y natural immunity neutralization ability neutralization activities neutralization activity neutralization assays Neutralizing Predictive markers quantification RBD RBD-ACE2 Receptor binding domain reduced SARS-CoV-2 SARS-CoV-2 variants several variants severity subject Support Translational research Transmission vaccinated individual vaccinated individuals vaccine-induced antibody Vaccines variant variants of SARS-CoV-2 viral infection Virology while [DOI] 10.1038/s41598-022-06629-2 PMC 바로가기 [Article Type] Article
SARS‐CoV‐2 Omicron variant: A next phase of the COVID‐19 pandemic and a call to arms for system sciences and precision medicinePerspective Published on 2022-02-112022-10-30 Journal: MedComm [Category] COVID-19, [키워드] 3D models Arm artificial B.1.1.529 continuous variation coronavirus disease correlated COVID‐19 COVID‐19 infection Defense delta variant diagnose diagnostics Efficiency exhibited Health health systems high mortality Hospitalization in vitro Infection intelligence introduced mechanism mutated Mutation mutations nanomedicine natural immunity omicron pandemic Pathogenesis Perspective Precision precision medicine provided receptor‐binding domain recommendation reservoirs Respiratory Coronavirus SARS‐CoV‐2 SARS‐CoV‐2 mutations severity Spread Structure subtype System the spike protein Vaccines variant variants viral infection virus VOCs World Health Organization [DOI] 10.1002/mco2.119 PMC 바로가기 [Article Type] Perspective
Clinical Characteristics and Outcomes of COVID-19 Hospitalized Patients: A Comparison between Complete mRNA Vaccination Profile and Natural ImmunityArticle Published on 2022-02-102022-10-30 Journal: Journal of Personalized Medicine [Category] COVID-19, [키워드] 1:1 age and gender Antibody Response Beta BNT162b2 Breakthrough infection circulating clinical conducted control group COVID-19 Delta eligible Epidemiological study higher risk Hospital admission immunization individual infected individuals infected with SARS-CoV-2 Infection laboratory data Mortality mRNA mRNA vaccine natural natural immunity neutralization no significant difference Non-invasive outcome oxygen supplementation Patient patients with SARS-CoV-2 Pfizer/BioNTech profile provided Reinfection required risk of infection Romania SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant second dose Severe COVID-19 Infection severity statistically study groups vaccination Variation [DOI] 10.3390/jpm12020259 PMC 바로가기 [Article Type] Article
Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variantsSARS-CoV-2 WA1/2020에 대한 이전 감염은 B.1.1.7 및 B.1.351 변이체에 의한 재감염으로부터 붉은털 원숭이를 부분적으로 보호합니다.Article Published on 2022-02-032022-09-10 Journal: Science Translational Medicine [Category] MERS, SARS, 변종, 진단, [키워드] (alpha (Beta acute respiratory syndrome acute respiratory syndrome coronavirus Alpha B.1.1.7 B.1.351 B.1.351 variant B.1.351 variants coronavirus Critical Efficacy high viral replication Immunity implication Infection infection with SARS-CoV-2 leads Lower respiratory tract natural natural immunity Neutralizing antibodies neutralizing antibody PROTECT Protective public health question Reinfection respiratory rhesus macaque rhesus macaques robust SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants SARS-CoV-2 WA1/2020 strain severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 the SARS-CoV-2 These data Transmissibility upper and lower respiratory tract vaccination variant variants Viral WA1/2020 [DOI] 10.1126/scitranslmed.abj2641 PMC 바로가기 [Article Type] Article